[年龄对瘤治疗的影响]
Florence Rollot Trad1, Monica Pierro1,2, Soraya Mebarki2
1Unité d'oncogériatrie, département des soins de support, institut Curie, Paris, France.
La Revue du praticien
|February 23, 2026
概括
由于患者的异质性和脆弱性,对老年人癌症的管理是复杂的. 在老年瘤学中,全面老年评估 (CGA) 对于个性化治疗和改善生活质量至关重要.
科学领域:
- 老年瘤学 老年瘤学
- 公共卫生 公共卫生
- 癌症护理 癌症护理
背景情况:
- 人口老龄化增加了癌症发病率,这给公共卫生带来了挑战.
- 患有癌症的老年人是异质的,面临着并发症,脆弱和多药性.
- 尽管取得了进展,但老年癌症患者的生存率较低,受到年龄歧视和脆弱的影响.
研究的目的:
- 突出脆弱性评估在治疗癌症的老年人中的重要性.
- 强调综合老年学评估 (CGA) 在定制治疗策略中的作用.
- 概述一个多学科的方法,以优化护理和生活质量.
主要方法:
- 使用G8工具对老年癌症患者进行初始查.
- 执行综合老年病评估 (CGA) 来分析多维患者状态.
- 实施个性化,多学科的管理策略.
主要成果:
- CGA提供了诊断,预后和干预价值.
- CGA经常导致最初的癌症治疗计划的修改.
- 基于CGA的发现,可以实施有针对性的非瘤干预措施.
结论:
- 脆弱性评估和CGA对于适应老年人癌症治疗至关重要.
- 综合支持性干预的多学科,个性化护理至关重要.
- 有效的沟通和协调是维护自治和生活质量的关键.
关键词:
癌症 癌症 癌症 癌症 癌症相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
267
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
267
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
298
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
298
Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
761
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
761
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
283
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
283
Drug Dosing: Geriatric Patients
319
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
319
